WO2022266557A3 - Bovine supplement for neonatal calves - Google Patents

Bovine supplement for neonatal calves Download PDF

Info

Publication number
WO2022266557A3
WO2022266557A3 PCT/US2022/040059 US2022040059W WO2022266557A3 WO 2022266557 A3 WO2022266557 A3 WO 2022266557A3 US 2022040059 W US2022040059 W US 2022040059W WO 2022266557 A3 WO2022266557 A3 WO 2022266557A3
Authority
WO
WIPO (PCT)
Prior art keywords
supplement
bovine
neonatal
delivers
caffeine
Prior art date
Application number
PCT/US2022/040059
Other languages
French (fr)
Other versions
WO2022266557A2 (en
WO2022266557A4 (en
Inventor
Nathan C. UPAH
Aaron N. FRITCHEN
Dennis M. MCKILLIGAN
Bradley W. KOLSTAD
Original Assignee
Techmix, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/351,598 external-priority patent/US20220387436A1/en
Application filed by Techmix, Inc. filed Critical Techmix, Inc.
Priority to CA3224052A priority Critical patent/CA3224052A1/en
Priority to EP22825982.6A priority patent/EP4355111A2/en
Priority to AU2022291939A priority patent/AU2022291939A1/en
Publication of WO2022266557A2 publication Critical patent/WO2022266557A2/en
Publication of WO2022266557A3 publication Critical patent/WO2022266557A3/en
Publication of WO2022266557A4 publication Critical patent/WO2022266557A4/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates generally to a feed supplement preparation for administration to ruminant animals and, more particularly, to a formulation for an oral bovine supplement for neonatal calves that delivers naturally occurring caffeine, in a stable liquid form of elevated viscosity and optionally antioxidants and other electrolytes. A 10-40 ml liquid dose of the supplement containing green tea extract delivers a concentrated amount of caffeine of about 100-400 mg to the neonatal calf.
PCT/US2022/040059 2021-06-18 2022-08-11 Bovine supplement for neonatal calves WO2022266557A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA3224052A CA3224052A1 (en) 2021-06-18 2022-08-11 Bovine supplement for neonatal calves
EP22825982.6A EP4355111A2 (en) 2021-06-18 2022-08-11 Bovine supplement for neonatal calves
AU2022291939A AU2022291939A1 (en) 2021-06-18 2022-08-11 Bovine supplement for neonatal calves

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17/351,598 2021-06-18
US17/351,598 US20220387436A1 (en) 2018-08-30 2021-06-18 Bovine supplement for neonatal calves

Publications (3)

Publication Number Publication Date
WO2022266557A2 WO2022266557A2 (en) 2022-12-22
WO2022266557A3 true WO2022266557A3 (en) 2023-03-02
WO2022266557A4 WO2022266557A4 (en) 2023-04-13

Family

ID=84526576

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2022/040059 WO2022266557A2 (en) 2021-06-18 2022-08-11 Bovine supplement for neonatal calves

Country Status (4)

Country Link
EP (1) EP4355111A2 (en)
AU (1) AU2022291939A1 (en)
CA (1) CA3224052A1 (en)
WO (1) WO2022266557A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150225485A1 (en) * 2003-04-04 2015-08-13 Genentech, Inc. High concentration antibody and protein formulations
US20150238573A1 (en) * 2004-05-24 2015-08-27 Nutrinia Ltd. Nutritional food and feed, composition, processing and method of use
US20170105949A1 (en) * 2014-03-26 2017-04-20 Rivalea (Australia) Pty Ltd Method for improving feed efficiency in ruminants
US20200069692A1 (en) * 2018-08-30 2020-03-05 Techmix, Llc Bovine supplement for neonatal calves

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150225485A1 (en) * 2003-04-04 2015-08-13 Genentech, Inc. High concentration antibody and protein formulations
US20150238573A1 (en) * 2004-05-24 2015-08-27 Nutrinia Ltd. Nutritional food and feed, composition, processing and method of use
US20170105949A1 (en) * 2014-03-26 2017-04-20 Rivalea (Australia) Pty Ltd Method for improving feed efficiency in ruminants
US20200069692A1 (en) * 2018-08-30 2020-03-05 Techmix, Llc Bovine supplement for neonatal calves

Also Published As

Publication number Publication date
EP4355111A2 (en) 2024-04-24
AU2022291939A1 (en) 2024-01-18
WO2022266557A2 (en) 2022-12-22
CA3224052A1 (en) 2022-12-22
WO2022266557A4 (en) 2023-04-13

Similar Documents

Publication Publication Date Title
JP5424401B2 (en) Ruminant bloating control agent
KR100831511B1 (en) Formulation for menopausal women
US20080020022A1 (en) Chewable co-enzyme q-10 capsule
ES2687416T3 (en) Agent to improve milk production and / or ruminant milk quality
US9585852B2 (en) Agmatine containing dietary supplements, nutraceuticals and foods
JP5484340B2 (en) Ruminant bloating treatment
EP3115047A1 (en) Debility preventative
WO2022266557A3 (en) Bovine supplement for neonatal calves
WO2010030470A1 (en) Agmatine containing dietary supplements, nutraceuticals, and foods
JPWO2010053085A1 (en) Ruminant acidosis control agent
CA3110325C (en) Bovine supplement for neonatal calves
US20140255524A1 (en) Alpha-gpc dietary supplements for weight loss and/or increasing or maintaining lean body mass
US20220370393A1 (en) Method and composition for increasing muscle protein synthesis
CN108653716A (en) A kind of tealeaves essence drunk-sobering tablet and preparation method thereof
US20100041679A1 (en) Oral dieting composition comprising conjugated linoleic acid and caffeine
US20100272836A1 (en) Composition for increasing milk production containing artemisia capillaris
US20140363504A1 (en) Absorbable encapsulated calcium in hypromellose capsule
JP7257715B2 (en) oral composition
US20220370392A1 (en) Method and Composition for Increasing Muscle Protein Synthesis
CN112514996B (en) Combination or composition, dairy product and use
WO2021112217A1 (en) Composition for suppressing increase in amount of neutral fat in liver
WO2020244798A1 (en) Method for taste/odor masking of a product for chronic kidney disease patients
JP2022059811A (en) Absorption enhancer of cinnamic acid derivative
JP4089874B2 (en) Coenzyme Q10-containing beverage
US9308261B2 (en) Compositions and methods for treating varicose veins

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22825982

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2022291939

Country of ref document: AU

Ref document number: 3224052

Country of ref document: CA

Ref document number: 806625

Country of ref document: NZ

Ref document number: AU2022291939

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2023578180

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2022291939

Country of ref document: AU

Date of ref document: 20220811

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2022825982

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2022825982

Country of ref document: EP

Effective date: 20240118

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22825982

Country of ref document: EP

Kind code of ref document: A2